Hirschsprung's disease medical therapy: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Medications only play a supportive role in the management of Hirschsprung's disease. They are indicated to prevent complications of Hirschsprung disease, to prevent infections during reconstructive surgery, and to manage postoperative bowel function. | Medications only play a supportive role in the management of Hirschsprung's disease. They are indicated to prevent complications of Hirschsprung disease, to prevent infections during reconstructive surgery, and to manage postoperative bowel function. Intravenous fluid resuscitation and maintenance, nasogastric decompression, and administration of intravenous antibiotics (as indicated) remain the cornerstones of initial medical management. | ||
==Medical Therapy== | ==Medical Therapy== | ||
Revision as of 15:00, 16 June 2017
|
Hirschsprung's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hirschsprung's disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Hirschsprung's disease medical therapy |
|
Risk calculators and risk factors for Hirschsprung's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medications only play a supportive role in the management of Hirschsprung's disease. They are indicated to prevent complications of Hirschsprung disease, to prevent infections during reconstructive surgery, and to manage postoperative bowel function. Intravenous fluid resuscitation and maintenance, nasogastric decompression, and administration of intravenous antibiotics (as indicated) remain the cornerstones of initial medical management.